Novel YcbQ Pili of Enterohemorrhagic E. coli O157:H7

肠出血性大肠杆菌O157:H7的新型YcbQ菌毛

基本信息

  • 批准号:
    7201648
  • 负责人:
  • 金额:
    $ 24.98万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-09-15 至 2008-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Enterohemorrhagic E. coil (EHEC) O157:H7 is recognized as an important emerging pathogen responsible for producing hemorrhagic colitis and the hemolytic uremic syndrome (HUS) in humans. EHEC O157:H7 strains elaborate a potent Shiga toxin, which has been associated with the pathogenesis of HUS. No pili have yet been reproducibly identified in O157:H7 strains and therefore, it is still an enigma as to whether pili play a role in colonization of the intestine of their natural bovine or accidental human hosts. We have recently identified and purified a novel pilus structure produced by EHEC strain EDL933 and other O157:H7 strains. These pili are composed of an 18- kDa pilin subunit and its amino terminus shows identity to the predicted product of the ycbQ gene contained in the EDL933 chromosome. Sequence comparison analysis revealed that these pili, herein called YcbQ, belong to the virulence-associated pili family composed of F17, K99, and G pili found in several animal and human pathogenic E. coli strains, and CupA pili of Pseudomonas aeruginosa. Four genes (ycbQ, ycbR, ycbS, ycbT) with homology to F17 family piliation genes were identified by sequence homology in the genome of EDL933, being ycbQ the structural gene. Overall, the objective of this proposal is to advance knowledge of EHEC pathogenesis by elucidating the mechanism(s) of adherence of EHEC O157:H7 to human epithelial cells in culture. Several multidisciplinary approaches involving molecular biology, cell biology, ultrastructural analysis by high power electron microscopy, and biochemical and antigenic analysis will be carded out to extend our current knowledge on the interaction of EHEC O157:H7 with host target cells. The outcome of this proposal will provide important implications for diagnosis of EHEC disease and detection of O157:H7 in food sources and reservoirs. The information obtained will be important for prevention and control strategies of EHEC infections. The central focus of this proposal lies in the following specific aims: 1) To define the genes required for YcbQ pili biogenesis; 2) Define the role of YcbQ pili; and 3) Study transcriptional expression of ycb genes.
描述(由申请人提供):肠出血性大肠杆菌(EHEC) O157:H7被认为是一种重要的新兴病原体,负责在人类中产生出血性结肠炎和溶血性尿毒症综合征(HUS)。肠出血性大肠杆菌O157:H7菌株产生一种强效志贺毒素,这种毒素与溶血性尿毒症的发病机制有关。在O157:H7菌株中尚未发现可重复的菌毛,因此,菌毛是否在其天然牛或偶然的人类宿主的肠道定植中发挥作用仍然是一个谜。我们最近鉴定并纯化了由EHEC菌株EDL933和其他O157:H7菌株产生的一种新的菌毛结构。这些毛由一个18 kDa的毛蛋白亚基组成,其氨基末端与EDL933染色体中含有的ycbQ基因的预测产物一致。序列比较分析表明,这些毛被称为YcbQ,属于毒力相关毛家族,由多种动物和人致病性大肠杆菌菌株中的F17、K99和G毛以及铜绿假单胞菌的CupA毛组成。通过序列同源性分析,EDL933基因组中有4个与F17家族亲缘关系基因同源的基因(ycbQ、ycbR、ycbS、ycbT),其中ycbQ为结构基因。总的来说,本研究的目的是通过阐明EHEC O157:H7粘附于培养的人上皮细胞的机制来推进对EHEC发病机制的了解。将梳理包括分子生物学、细胞生物学、高功率电子显微镜超微结构分析、生化和抗原分析在内的多学科方法,以扩展我们目前对肠出血性大肠杆菌O157:H7与宿主靶细胞相互作用的了解。这一建议的结果将为肠出血性大肠杆菌疾病的诊断和O157:H7在食物来源和储藏库中的检测提供重要意义。获得的信息将对肠出血性大肠杆菌感染的预防和控制策略具有重要意义。本研究的核心目标是:1)确定YcbQ菌毛生物发生所需的基因;2)明确YcbQ菌群的作用;3)研究ycb基因的转录表达。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The Escherichia coli ycbQRST operon encodes fimbriae with laminin-binding and epithelial cell adherence properties in Shiga-toxigenic E.  coli O157:H7.
大肠杆菌 ycbQRST 操纵子编码产志贺毒素大肠杆菌 O157:H7 中具有层粘连蛋白结合和上皮细胞粘附特性的菌毛。
  • DOI:
    10.1111/j.1462-2920.2009.01906.x
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    5.1
  • 作者:
    Samadder,Partha;Xicohtencatl-Cortes,Juan;Saldaña,Zeus;Jordan,Dianna;Tarr,PhillipI;Kaper,JamesB;Girón,JorgeA
  • 通讯作者:
    Girón,JorgeA
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JORGE A GIRON其他文献

JORGE A GIRON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JORGE A GIRON', 18)}}的其他基金

Dissecting the role of fimbrial repertoire in Enteroaggregative Escherichia coli
剖析菌毛在肠聚集性大肠杆菌中的作用
  • 批准号:
    8823332
  • 财政年份:
    2015
  • 资助金额:
    $ 24.98万
  • 项目类别:
YagZ Pilus Adhesin of Attaching and Effacing E. coli
YagZ 菌毛粘附素对大肠杆菌的附着和消除作用
  • 批准号:
    7900663
  • 财政年份:
    2006
  • 资助金额:
    $ 24.98万
  • 项目类别:
YagZ Pilus Adhesin of Attaching and Effacing E. coli
YagZ 菌毛粘附素对大肠杆菌的附着和消除作用
  • 批准号:
    7665019
  • 财政年份:
    2006
  • 资助金额:
    $ 24.98万
  • 项目类别:
YagZ Pilus Adhesin of Attaching and Effacing E. coli
YagZ 菌毛粘附素对大肠杆菌的附着和消除作用
  • 批准号:
    7106096
  • 财政年份:
    2006
  • 资助金额:
    $ 24.98万
  • 项目类别:
YagZ Pilus Adhesin of Attaching and Effacing E. coli
YagZ 菌毛粘附素对大肠杆菌的附着和消除作用
  • 批准号:
    7941706
  • 财政年份:
    2006
  • 资助金额:
    $ 24.98万
  • 项目类别:
YagZ Pilus Adhesin of Attaching and Effacing E. coli
YagZ 菌毛粘附素对大肠杆菌的附着和消除作用
  • 批准号:
    7227050
  • 财政年份:
    2006
  • 资助金额:
    $ 24.98万
  • 项目类别:
YagZ Pilus Adhesin of Attaching and Effacing E. coli
YagZ 菌毛粘附素对大肠杆菌的附着和消除作用
  • 批准号:
    7425326
  • 财政年份:
    2006
  • 资助金额:
    $ 24.98万
  • 项目类别:
Novel YcbQ Pili of Enterohemorrhagic E. coli O157:H7
肠出血性大肠杆菌O157:H7的新型YcbQ菌毛
  • 批准号:
    7015564
  • 财政年份:
    2004
  • 资助金额:
    $ 24.98万
  • 项目类别:
Novel Type IV Pili of Enterohemorrhagic E. coli O157:H7
肠出血性大肠杆菌 O157:H7 的新型 IV 菌毛
  • 批准号:
    6811345
  • 财政年份:
    2004
  • 资助金额:
    $ 24.98万
  • 项目类别:
Novel YcbQ Pili of Enterohemorrhagic E. coli O157:H7
肠出血性大肠杆菌O157:H7的新型YcbQ菌毛
  • 批准号:
    6862183
  • 财政年份:
    2004
  • 资助金额:
    $ 24.98万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 24.98万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 24.98万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 24.98万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 24.98万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 24.98万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 24.98万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 24.98万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 24.98万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 24.98万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 24.98万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了